EMA Panel Recommends Once-Daily HIV-1 Treatment Biktarvy EMA Panel Recommends Once-Daily HIV-1 Treatment Biktarvy

EMA panel recommends marketing authorization for a once-daily HIV-1 combo containing bictegravir, emtricitabine, and tenofovir.International Approvals
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: HIV/AIDS News Alert Source Type: news